Your browser doesn't support javascript.
loading
Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review.
Patel, Girijesh Kumar; Perry, Josiah B; Abdul-Rahim, Osama; Frankel, Arthur E; Cameron, Daniel; Taylor, William; Rocconi, Rodney P; Abushahin, Laith; Nelson, Cindy; Singh, Ajay P; Khushman, Moh'd.
  • Patel GK; Department of Oncologic Sciences, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA.
  • Perry JB; College of Allied Health Professions, The University of South Alabama, Mobile, Alabama, USA.
  • Abdul-Rahim O; Division of Interventional Radiology, The University of South Alabama, Mobile, Alabama, USA.
  • Frankel AE; Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA.
  • Cameron D; Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA.
  • Taylor W; Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA.
  • Rocconi RP; Gynecology Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA.
  • Abushahin L; Medical Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Nelson C; Division of Interventional Radiology, The University of South Alabama, Mobile, Alabama, USA.
  • Singh AP; Department of Oncologic Sciences, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama, USA.
  • Khushman M; Division of Interventional Radiology, The University of South Alabama, Mobile, Alabama, USA.
J Cancer Res Ther ; 16(4): 950-954, 2020.
Article en En | MEDLINE | ID: mdl-32930150
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Clorhidrato de Erlotinib / Mutación Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Clorhidrato de Erlotinib / Mutación Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article